Method for producing paeonin metabolite-I by short lactobacillin fermentation
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHENGDU INST OF BIOLOGY CHINESE ACAD OF S
- Publication Date
- 2007-11-21
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention belongs to the field of biochemical engineering, and relates to a method for producing paeoniflorin metabolite-I by fermenting lactobacillus. Background technique
[0002] Paeoniflorin is the main active ingredient of Paeoniflorin, which has various effects such as analgesic and antispasmodic, anti-inflammatory, anti-stress ulcer, expansion of coronary vessels, anti-acute myocardial ischemia and inhibition of platelet aggregation. Recent studies have shown that after oral administration of paeoniflorin, there is little direct absorption and low bioavailability, suggesting that paeoniflorin is first degraded by intestinal bacteria in the intestinal tract, and its metabolites play the pharmacological role of paeoniflorin. Japan's Masao Hattori et al. first reported that paeoniflorin was converted into paeoniflorin metabolin-I, II, III (see Figure 1 for Paeonimatabolin-I, II, III) in human intestinal bacteria in v...